Xeris Biopharma to Report Third-Quarter Financial Results
Bitget2026/10/22 12:08- Xeris Biopharma will release third-quarter 2026 financial results before U.S. markets open on Nov. 5, 2026.
- Management will host a conference call and webcast on Nov. 5 at 8:30 a.m. ET to discuss results and business highlights.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
CoreWeave downplays Jensen Huang's departure, says Nvidia remains a key partner
CoreWeave’s Vice President of Strategy stated that the company will continue its partnership with Nvidia, with hundreds or even thousands of layers of business collaboration between the two sides. Nvidia is a vast institution, not reliant on a single individual for its operations. However, this statement failed to boost market sentiment, and CoreWeave’s stock is currently down more than 5% during intraday trading.


Phoenix hits broad gold and copper at old BC mine
